Dr. Sanogo has extensive experience as a HERO, RWE, and DS consultant in the pharmaceutical industry. He served as an assistant scientist in the Department of Pharmaceutical Outcomes and Policy at the University of Florida College of Pharmacy. He holds a master’s in economics from the University of Cote D’Azur (FR), a Master in Corporate Finance from INSEEC Business School of Paris, and a Ph.D. in economics from the University of Cote D’Azur. Recently, he earned a master’s in Data Science from Northcentral University in San Diego, USA.
Dr. Sanogo has also worked as a Research Fellow at the Center for Economic Forecasting and Analysis at Florida State University (FSU) and as a Lecturer in economics at Tallahassee Community College (TCC), where he taught principles of economics. His research includes cost-effectiveness studies, econometric evaluations, and leading projects on health policy, health outcomes, financial development, economic growth, and small business development program evaluation. Currently, his research focuses on economic impact assessments, health policy and technology changes, and healthcare access and disparities among Alzheimer’s disease and related dementia patients.
Dr. Almutairi has extensive experience as a HEOR and RWE consultant in the pharmaceutical industry. She served as an assistant professor in the Department of Pharmacy at the College of Pharmacy. She earned her master’s in Pharmaceutical Economics and Policy from MCPHS University in Boston and a master’s in clinical pharmacy from KSU. Dr. Almutairi also holds a Ph.D. from MCPHS University, specializing in Pharmaceutical Economics and Policy.
Additionally, she worked as a Research Assistant with the Cushing Neurosurgical Outcomes Center, Department of Neurosurgery, at Brigham and Women’s Hospital, Harvard Medical School, in Boston, MA. She has taught courses on health economics evaluation, pharmaceutical policy and regulation, decision-analytic modeling techniques, and evidence-based medicine at academic universities. Dr. Almutairi has also collaborated with many faculty members in academic settings on various research projects. Her research includes cost-effectiveness studies, budget impact models, and cost utility analyses for pharmaceuticals. Her areas of specialization include Real-World Evidence and Evidence Synthesis, Economic Evaluation, and Market Access and Pricing Strategy. She has led several projects in health economics and policy, evidence synthesis, and health outcomes, focusing on central nervous disease, nephrology, and oncology. Dr. Almutairi is serving as a reviewer for medical journals and international conferences, has presented her work at professional conferences, and published in peer-reviewed journals. Currently, her research focuses on economic impact assessments, evaluation, and health policy.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.